相似文献
1
Hereditary hemochromatosis in the post-HFE era.
Hepatology. 2008 Sep;48(3):991-1001. doi: 10.1002/hep.22507.
2
Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
Blood Cells Mol Dis. 2007 Jan-Feb;38(1):37-44. doi: 10.1016/j.bcmd.2006.09.008. Epub 2006 Nov 13.
3
Possible roles of the hereditary hemochromatosis protein, HFE, in regulating cellular iron homeostasis.
Biol Res. 2006;39(1):105-11. doi: 10.4067/s0716-97602006000100013.
4
HFE and non-HFE hemochromatosis.
Int J Hematol. 2002 Oct;76(3):203-7. doi: 10.1007/BF02982788.
5
Recent advances in hemochromatosis: a 2015 update : a summary of proceedings of the 2014 conference held under the auspices of Hemochromatosis Australia.
Hepatol Int. 2015 Apr;9(2):174-82. doi: 10.1007/s12072-015-9608-2. Epub 2015 Mar 12.
6
HFE, the MHC and hemochromatosis: paradigm for an extended function for MHC class I.
Tissue Antigens. 2003 Apr;61(4):263-75. doi: 10.1034/j.1399-0039.2003.00065.x.
7
HFE gene knockout produces mouse model of hereditary hemochromatosis.
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2492-7. doi: 10.1073/pnas.95.5.2492.
8
Recent advances in the pathophysiology, diagnosis and treatment of hereditary hemochromatosis and other iron overload syndromes.
Adv Clin Path. 2001 Oct;5(4):121-31.
9
Hereditary haemochromatosis.
Best Pract Res Clin Gastroenterol. 2009;23(2):171-83. doi: 10.1016/j.bpg.2009.02.004.
10
Hereditary hemochromatosis: impact of molecular and iron-based testing on the diagnosis, treatment, and prevention of a common, chronic disease.
Arch Pathol Lab Med. 1999 Nov;123(11):1053-9. doi: 10.5858/1999-123-1053-HH.
引用本文的文献
1
MicroRNAs in Liver Cirrhosis: Diagnostic and Therapeutic Perspectives-A Comprehensive Review.
J Pers Med. 2025 Aug 14;15(8):376. doi: 10.3390/jpm15080376.
2
New Deferric Amine Compounds Efficiently Chelate Excess Iron to Treat Iron Overload Disorders and to Prevent Ferroptosis.
Adv Sci (Weinh). 2022 Oct;9(29):e2202679. doi: 10.1002/advs.202202679. Epub 2022 Aug 28.
3
Effects of Excess Iron on the Retina: Insights From Clinical Cases and Animal Models of Iron Disorders.
Front Neurosci. 2022 Feb 3;15:794809. doi: 10.3389/fnins.2021.794809. eCollection 2021.
4
Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies.
J Clin Apher. 2022 Feb;37(1):100-105. doi: 10.1002/jca.21956. Epub 2021 Dec 13.
5
Pathogenesis, Diagnosis, and Clinical Implications of Hereditary Hemochromatosis-The Cardiological Point of View.
Diagnostics (Basel). 2021 Jul 16;11(7):1279. doi: 10.3390/diagnostics11071279.
6
Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis.
Sci Rep. 2021 Jul 19;11(1):14654. doi: 10.1038/s41598-021-94083-x.
7
Association between Bone Mineral Density and Serum Iron Indices in Premenopausal Women in South Korea.
Korean J Fam Med. 2020 May;41(3):175-182. doi: 10.4082/kjfm.18.0142. Epub 2020 May 20.
8
Transferrin and H-ferritin involvement in brain iron acquisition during postnatal development: impact of sex and genotype.
J Neurochem. 2020 Feb;152(3):381-396. doi: 10.1111/jnc.14834. Epub 2019 Aug 22.
9
Endocrine dysfunction in hereditary hemochromatosis.
J Endocrinol Invest. 2016 Aug;39(8):837-47. doi: 10.1007/s40618-016-0451-7. Epub 2016 Mar 7.
10
Modulation of hepcidin to treat iron deregulation: potential clinical applications.
Expert Rev Hematol. 2016;9(2):169-86. doi: 10.1586/17474086.2016.1124757. Epub 2015 Dec 15.
本文引用的文献
1
Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosis.
J Hepatol. 2010 Mar;52(3):425-31. doi: 10.1016/j.jhep.2009.12.010. Epub 2010 Jan 6.
2
Noncitrus fruits as novel dietary environmental modifiers of iron stores in people with or without HFE gene mutations.
Mayo Clin Proc. 2008 May;83(5):543-9. doi: 10.4065/83.5.543.
3
Iron homeostasis: fitting the puzzle pieces together.
Cell Metab. 2008 Apr;7(4):288-90. doi: 10.1016/j.cmet.2008.03.008.
4
HFE association with transferrin receptor 2 increases cellular uptake of transferrin-bound iron.
Arch Biochem Biophys. 2008 Jun 1;474(1):193-7. doi: 10.1016/j.abb.2008.02.041. Epub 2008 Mar 7.
5
Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha.
Blood. 2008 Jun 15;111(12):5727-33. doi: 10.1182/blood-2007-08-106195. Epub 2008 Mar 7.
6
Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis.
Blood. 2008 May 1;111(9):4456-62. doi: 10.1182/blood-2007-11-122374. Epub 2008 Mar 3.
7
The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.
Cell Metab. 2008 Mar;7(3):205-14. doi: 10.1016/j.cmet.2007.11.016.
8
Hfe acts in hepatocytes to prevent hemochromatosis.
Cell Metab. 2008 Feb;7(2):173-8. doi: 10.1016/j.cmet.2007.11.014.
9
Iron-overload-related disease in HFE hereditary hemochromatosis.
N Engl J Med. 2008 Jan 17;358(3):221-30. doi: 10.1056/NEJMoa073286.
10
Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription.
Gastroenterology. 2008 Jan;134(1):226-38. doi: 10.1053/j.gastro.2007.10.011. Epub 2007 Oct 9.
Zotero 插件